Activity Objectives Explain the mechanism of action of glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), including effects on insulin, glucagon, gastric emptying, and appetite. Differentiate the clinical indications for GLP-1 therapies and select appropriate candidates based on patient-specific goals. Name key contraindications to utilizing GLP-1 therapies. Identify clinically significant adverse effects associated with GLP-1 therapies and describe how to practically mitigate these adverse effects in your practice. Outline a structured approach to insurance navigation for patients prescribed GLP-1 therapies, including discussing cost-reduction strategies to improve patient access and persistence.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12800 Corporate Hill Drive
Pricing
100% of listed courses are free
5 of 5 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
-
ReleasedJun 4, 2026
-
Last day to claim creditJun 5, 2028 2 years left
